Narcolepsy Treatment Market: Rising Adoption of BiPAP Therapy to Propel Growth
In the past decades, scientists have made significant development in assessing narcolepsy and identifying genes linked with disorder. The loss of hypocretin-producing neurons have led to the day-time symptoms and sleep fragmentation which people with narcolepsy experience. After studying people right after they develop the disorder, the scientists have discovered people with narcolepsy have high levels of anti-streptolysin O antibodies, alluding an immune response to a latest bacterial infection. Meanwhile, the year 2009 witnessed H1N1 influenza epidemic resulting in growing...
View full press release